scholarly journals Decreasing nicotinic receptor activity and the spatial learning impairment caused by the NMDA glutamate antagonist dizocilpine in rats

2014 ◽  
Vol 741 ◽  
pp. 132-139 ◽  
Author(s):  
Dennis A. Burke ◽  
Pooneh Heshmati ◽  
Ehsan Kholdebarin ◽  
Edward D. Levin
2013 ◽  
Vol 12 (4) ◽  
pp. 414-423 ◽  
Author(s):  
E. Azzopardi ◽  
M. Typlt ◽  
B. Jenkins ◽  
S. Schmid

2001 ◽  
Vol 21 (19) ◽  
pp. 7463-7473 ◽  
Author(s):  
Corey Hilmas ◽  
Edna F. R. Pereira ◽  
Manickavasagom Alkondon ◽  
Arash Rassoulpour ◽  
Robert Schwarcz ◽  
...  

2001 ◽  
Vol 15 ◽  
pp. S19-S25 ◽  
Author(s):  
E. X. Albuquerque ◽  
M. D. Santos ◽  
M. Alkondon ◽  
E. F. R. Pereira ◽  
A. Maelicke

1996 ◽  
Vol 16 (10) ◽  
pp. 3427-3443 ◽  
Author(s):  
Kiminobu Sugaya ◽  
Michael Chouinard ◽  
Rhonda Greene ◽  
Michael Robbins ◽  
David Personett ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-2 ◽  
Author(s):  
Rohit Kant Srivastava ◽  
Medhavi Agarwal ◽  
Ashish Pundhir

A woman consulted psychiatric Out-Patient Department (OPD) for her 5-year and 2-month-old son presenting with typical autistic symptoms like social, behavioural, and communicational ineptitudeness. Subsequent treatment with Donepezil resulted in marked improvement in the aforementioned symptomatology. Recent studies in autistic child have shown diminished acetylcholine and nicotinic receptor activity, thus an acetylcholinergic enhancer, Donepezil, likely accounts for improvement in autistic symptoms. Evidently, the case report consolidates Donepezil role as a potentially useful agent in the treatment of cognitive and behavioural symptoms observed in this disorder.


Sign in / Sign up

Export Citation Format

Share Document